首页 › 基金 › Redmile Group, LLC › STTK
Redmile Group, LLC 对 STTK 的持仓历史
SHATTUCK LABS INC · 医疗保健
Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 STTK(SHATTUCK LABS INC)6,892,033 股,市值约 US$47.8M,约占其申报组合的 3.21%,在其申报持仓中市值排名第 9 位。 Redmile Group, LLC 最近 12 个申报季度中有 12 个季度披露了 STTK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Redmile Group, LLC 对 STTK 的持仓演变
Redmile Group, LLC 于 Q3 2023 首次披露 STTK 持仓:5,619,914 股(约 US$8.5M)。 该持仓在 Q1 2024 达到峰值 5,615,489 股,市值约 US$50.2M。 在 12 次申报中,Redmile Group, LLC 1 次增持、1 次减持、9 次保持不变。 最近一期申报(Q2 2026)显示持股 6,892,033 股、市值约 US$47.8M,环比增持 1,352,309 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 5.62M | $8.54M | 新进 |
| Q4 2023 | 5.62M | $40.07M | 持有 |
| Q1 2024 | 5.62M | $50.20M | 持有 |
| Q2 2024 | 5.62M | $21.68M | 持有 |
| Q3 2024 | 5.62M | $19.60M | 持有 |
| Q4 2024 | 5.54M | $6.70M | 减持 |
| Q1 2025 | 5.54M | $5.26M | 持有 |
| Q2 2025 | 5.54M | $4.39M | 持有 |
| Q3 2025 | 5.54M | $13.24M | 持有 |
| Q4 2025 | 5.54M | $20.22M | 持有 |
| Q1 2026 | 5.54M | $35.62M | 持有 |
| Q2 2026 | 6.89M | $47.83M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 STTK 与 13F 数据
STTK(SHATTUCK LABS INC)属于医疗保健行业。我们追踪的基金中还有 57 只申报持有 STTK,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$43.8M), Prosight Management, LP (US$41.3M), Frazier Life Sciences Management, L.P. (US$26.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 STTK 的基金
- ORBIMED ADVISORS LLC 6.31M 股 · $43.76M · Q2 2026
- Prosight Management, LP 5.96M 股 · $41.35M · Q2 2026
- Frazier Life Sciences Management, L.P. 3.75M 股 · $26.02M · Q2 2026
- NEXTBio Capital Management LP 3.73M 股 · $25.87M · Q2 2026
- Deep Track Capital, LP 3.71M 股 · $25.72M · Q2 2026
- CLARK ESTATES INC/NY 1.43M 股 · $9.93M · Q2 2026
- Boxer Capital Management, LLC 1.00M 股 · $6.94M · Q2 2026
- S&G Foundation 435.75K 股 · $3.02M · Q2 2026
- West Tower Group, LLC 191.62K 股 · $1.31M · Q3 2026
- LBJ Family Wealth Advisors, Ltd. 82.18K 股 · $560.00K · Q3 2026
更多关于 Redmile Group, LLC
常见问题
How long has Redmile Group, LLC held STTK?
Redmile Group, LLC has disclosed STTK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in STTK?
As of Q2 2026, Redmile Group, LLC holds 6.89M shares of STTK (SHATTUCK LABS INC), valued at $47.83M, representing 3.21% of its reported portfolio and ranking #9.
Has Redmile Group, LLC been buying or selling STTK?
In the latest 13F filing (Q2 2026), Redmile Group, LLC increased its position in STTK. The position peaked in Q1 2024 at 5.62M shares.
Which other funds hold STTK?
Other major institutional holders of STTK include ORBIMED ADVISORS LLC, Prosight Management, LP, Frazier Life Sciences Management, L.P., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.